- Home
- FSBC vs ORIC Comparison
FSBC vs ORIC Comparison
Compare FSBC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- ORIC
- Stock Information
- Founded
- FSBC 2002
- ORIC 2014
- Country
- FSBC United States
- ORIC United States
- Employees
- FSBC N/A
- ORIC N/A
- Industry
- FSBC Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- ORIC Health Care
- Exchange
- FSBC Nasdaq
- ORIC Nasdaq
- Market Cap
- FSBC 565.6M
- ORIC 362.9M
- IPO Year
- FSBC 2021
- ORIC 2020
- Fundamental
- Price
- FSBC $30.03
- ORIC $11.03
- Analyst Decision
- FSBC Buy
- ORIC Strong Buy
- Analyst Count
- FSBC 4
- ORIC 9
- Target Price
- FSBC $34.75
- ORIC $18.29
- AVG Volume (30 Days)
- FSBC 57.6K
- ORIC 858.6K
- Earning Date
- FSBC 07-23-2025
- ORIC 08-11-2025
- Dividend Yield
- FSBC 2.65%
- ORIC N/A
- EPS Growth
- FSBC N/A
- ORIC N/A
- EPS
- FSBC 2.27
- ORIC N/A
- Revenue
- FSBC $124,973,000.00
- ORIC N/A
- Revenue This Year
- FSBC $26.05
- ORIC N/A
- Revenue Next Year
- FSBC $15.06
- ORIC N/A
- P/E Ratio
- FSBC $13.29
- ORIC N/A
- Revenue Growth
- FSBC 11.14
- ORIC N/A
- 52 Week Low
- FSBC $22.22
- ORIC $3.90
- 52 Week High
- FSBC $35.13
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- FSBC 67.17
- ORIC 64.08
- Support Level
- FSBC $29.87
- ORIC $10.60
- Resistance Level
- FSBC $30.80
- ORIC $11.57
- Average True Range (ATR)
- FSBC 0.76
- ORIC 0.57
- MACD
- FSBC 0.11
- ORIC -0.08
- Stochastic Oscillator
- FSBC 90.10
- ORIC 72.32
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.